INTRODUCTION
Chronic kidney disease (CKD) is an important condition because it leads to end-stage renal disease (ESRD) in many people, and is associated with an increased occurrence of cardiovascular and cerebrovascular disease and death [1, 2] . Depending on how CKD is defined, between 10 and 15% of the adult US population have dipstick positive proteinuria or an estimated glomerular filtration rate (eGFR) of less than 60 ml/min/1.73 m 2 [3] .
Major factors which predict the rate at which kidney function declines in patients with CKD are diabetes, the level of blood pressure, and the magnitude of urine protein excretion. In more recent times, African descent [4] , particularly when both the G1 and G2 risk alleles of the apolipoprotein L-1 (APOL1) gene are present [5 && ], and the blood levels of fibroblast growth factor 23 (FGF23) [6] are related to the rate of loss-of-kidney function in patients with established CKD.
Over the past decade, societies such as the National Kidney Foundation (NKF) and the American Diabetes Association (ADA) have consistently encouraged the pursuit of goal blood pressure and glucose targets in an effort to stem the tide of CKD progression [7] . Improvements in the achievement of blood pressure control, in cardiovascular interventions in those patients with atherosclerotic manifestations, and in the management of patients with CKD and comorbidities such as heart failure have increased the survival of patients with CKD.
These efforts may have changed the contemporary natural history of CKD since improvements in survival may be outstripping our ability to halt the progressive loss of kidney function, thereby allowing more patients to survive and develop ESRD, who, in the past years, might have succumbed to a cardiovascular or cerebrovascular event. To illustrate this point further, the 5% random Medicare sample of people enrolled in Medicare from 1996 to 2000, and who were followed for 2 years, indicated that a patient with CKD was at least five times more likely to die than to reach ESRD [8] . At the time of enrollment into the Chronic Renal Insufficiency Cohort (CRIC) study, about 34% of our participants had already experienced at least one cardiovascular event, including a myocardial infarction (MI), New York Heart Association (NYHA) heart failure stages I and II (stages III and IV were excluded), a stroke or transient ischemic attack, or a peripheral vascular intervention (angioplasty or lower-extremity amputation) [9] .
The main purpose in assembling the CRIC study was to evaluate the influence of traditional risk factors on CKD progression and the incidence, or worsening, of cardiovascular disease in a population with established CKD [10] . As such, it also represented the ideal circumstance to pursue the relationships of less traditional risk factors on the same endpoints. Arterial stiffness represents one such nontraditional risk factor, and a measure of arterial stiffness was incorporated into the CRIC protocol in 2005. Moreover, when compared with arm (carotidradial) or leg (femoral-posterior tibial) vascular segments, carotid-femoral pulse wave velocity (PWV) predicts outcomes clearly and robustly, whereas PWV measured in the arm or leg (in the same individuals as measured in the carotid-femoral segment) does not [11] . Measuring arterial stiffness using PWV is espoused by the European Society of Hypertension which recommendeds that the assessment of arterial stiffness be accomplished by measuring the PWV using waveform detection at a carotid and a femoral site, i.e., carotid-femoral PWV [12] . This can be done by tonometry, mechanotransduction, oscillometry, or ultrasound [13] . In the CRIC study, we measured carotid-femoral PWV using applanation tonometry [14] .
Lesson 1: the pulse wave velocity in patients with chronic kidney disease is much higher in patients with diabetes than those in the same age range without diabetes As shown in Fig. 1 , the PWV increased with age in CKD [14] . However, within any decade, the PWV was about 2 m/s higher in diabetic patients compared with the nondiabetic patients. Since the carotid-femoral PWV increases by roughly 1 m/s in a decade, this translates into about 20 years of 'aging' in the aorta of a diabetic CKD patient compared
with an approximately age-matched nondiabetic CKD patient.
Lesson 2: as estimated glomerular filtration rate declines, pulse wave velocity increases
This has been a topic of discussion in other CKD cohorts. Generally, reduced eGFR is associated with greater arterial stiffness [15 & ], but some studies were not able to show an independent contribution of decreased eGFR to increased PWV [16, 17] . In the CRIC study, we observed that each 10 ml/min/1.73 m 2 decline in eGFR was associated
KEY POINTS
Carotid-femoral pulse wave velocity provides insight into vascular health that is independent of the standard brachial blood pressure.
Carotid-femoral pulse wave velocity is a potent predictor of cardiovascular outcomes, particularly incident heart failure, in patients with chronic kidney disease.
Carotid-femoral pulse wave velocity is a valuable measure to include in longitudinal cohort studies, but remains an 'as-yet-untested' candidate for an intervention trial. Graphic re-drawn from published data in reference [14] . CRIC, Chronic Renal Insufficiency Cohort.
independently with a 0.23 m/s increase in PWV, as shown in Fig. 2 [14] .
Lesson 3: declining stages of kidney function have higher central aortic pressures
One consequence of increased arterial stiffness is greater reflection of the pulse wave back to the central aorta [18] . This happens because the PWV, like all waves, experiences reflection back upon its travel path when it meets branch points, plaque, and changes in the visco-elastic components in the wall of the conduit circulation vessels. As shown in Fig. 3 , the likelihood of a central pulse pressure of more than 50 mmHg -a value found to be a useful cut point in the Strong Heart Study [19] -was increasingly more prevalent as NKF kidney function stage worsened [20] . An important consequence of greater wave reflection is that it adds extra work to each left ventricular contraction, and may be important in the development of left ventricular hypertrophy and heart failure (see the section 'Lesson 4: increased pulse wave velocity predicts incident heart failure in chronic kidney disease').
Lesson 4: increased pulse wave velocity predicts incident heart failure in chronic kidney disease
As noted in the section 'Lesson 3: declining stages of kidney function have higher central aortic pressures', a consequence of greater arterial stiffness is a predisposition to heart failure. Heart failure is the most common reason people over the age of 60 years are admitted to the hospital in the United States [21] . In the CRIC PWV heart failure analyses, we specifically excluded participants with a history of NYHA stage I and II at enrollment and observed that increased PWV was associated with a greater likelihood of developing heart failure [22 && ]. This association was independent of blood pressure levels, sex, and the level of kidney function. Figure 4 compares the heart failure free survival of CRIC participants by tertile of PWV. These data show PWV to be an important and potent predictor of incident heart failure in CKD.
Lesson 5: increased arterial stiffness is associated with poorer cognitive function in chronic kidney disease
The brain and the kidney share one thing in common -they are low vascular resistance circulatory beds, and as a result, the pulse wave penetrates deeply into the microvascular level in these two organs [23] . We evaluated whether the PWV was associated, cross-sectionally, with cognitive Aortic pulse wave velocity (meters/second) eGFR in ml/min/1.73m 2 by increments of 10 (lighter) or by NKF stage (darker) in CRIC study participants 30 function tests in patients with CKD. Cognitive function testing was undertaken in the CRIC study, through an ancillary study, which allowed an extensive battery of tests to be administered to a subset of approximately 800 patients in the CRIC study [24] . Among these participants, 664 had a PWV measure either at the time of, or within 1 year of, cognitive function testing. Figure 5 shows examples of the relationship of PWV to two cognitive function measures as presented at the 2012 American Society of Nephrology (ASN) meeting in San Diego [25] . In the case of the Mini-Mental Status Exam (MMSE) test, a lower score was worse. In the case of trails B, a lower score in this test indicated better ability to connect numbers and letters during a timed testing period, so lower is better. As shown in the figure, quartiles of PWV were clearly, and independently of SBP, associated with Z-score-averaged values for these cognitive function tests. Increasing PWV was an independent predictor of cognitive function impairment in CKD.
Lesson 6: increased chronic kidney disease predicts further kidney function loss in patients with established chronic kidney disease
As noted in the section 'Lesson 5: increased arterial stiffness is associated with poorer cognitive function in chronic kidney disease', the low resistance in the kidney, as in the brain, may contribute to its vulnerability to trauma from the pressure wave. The level of blood pressure control in the CRIC study is surprisingly good, with average levels of blood pressure at enrollment of 128/71 mmHg and about 53% below NKF and ADA BP targets of less than 130/<80 mmHg [9] . Despite this reasonable level of blood pressure control, many CRIC participants still progress to ESRD. In the data we presented at the American Heart Association (AHA) Council for High Blood Pressure Research in September of 2014, we observed that CRIC participants with the highest tertiles of PWV (>10.8 m/s) and brachial pulse pressure (>62 mmHg) were about three-fold more likely to reach ESRD when compared with CRIC participants with the lowest tertile of PWV (<7.9 m/s) and the lowest tertile of pulse pressure (<46 mmHg). 
Z-score trails B
Pulse wave velocity quartiles (in meters/second) <7.9 7.9-9.5 9.5-11.7 >11.7 Lesson 7: the SBP at enrollment in the CRIC study was not highly associated with prevalent cardiovascular disease, whereas the pulse wave velocity was highly associated with prevalent cardiovascular disease and this association was independent of blood pressure
In data presented only in abstract form so far, we evaluated whether arterial stiffness (obtained about 2 years after enrollment) was associated with prevalent cardiovascular disease at enrollment into the CRIC study. Figure 6 shows the relationships between tertiles of PWV, and the prevalence of cardiovascular disease (self-reported by CRIC participants), broken down by three clinical age groupings. In multivariable analyses, PWV had a strong relationship to cardiovascular disease, whereas SBP had no significant association with prevalent cardiovascular disease in a model where both SBP and PWV were present.
Lesson 8: in chronic kidney disease, pulse wave velocity is predicted by proteins important in vascular calcification
Patients with vascular calcification are at substantially higher risk for cardiovascular events [26] . In CKD, a large body of data attests to disordered bone mineral metabolism [27] [28] [29] . We conducted an analysis to see if a biomarker-associated vascular calcification was related to PWV. We tested, among a subset of 226 participants who underwent concurrent PWV measurements and evaluation at a single-center CRIC ancillary study on bone metabolism, whether increasing tertiles of serum osteoprotegerin (OPG) were associated with PWV after adjustment for demographics, and a host of vascular risk factors including albuminuria, serum phosphate, corrected serum calcium, and C-reactive protein. We observed a modest but independent relationship of increasing tertiles of OPG with increasing PWV. Across the three tertiles of OPG, PWV was about 1 m/s higher in the highest compared with the lowest OPG tertile [30] . Percent with any CVD FIGURE 6. Data presented at regional symposium (no published abstract available). Shown are percentages of CRIC participants with any cardiovascular disease (self-report) at baseline in CRIC separated by age categories of 21-44 years, 45-64 years, and above 64 years. The graphic is subdivided by tertiles of pulse wave velocity within each age category. CRIC, Chronic Renal Insufficiency Cohort; CVD, cardiovascular disease.
of systolic pressure profile in the aorta from wave reflection is divided by the aortic pulse pressure to yield a unitless ratio (depicted as a %) [31] . This measure -the augmentation index -is easier to obtain than PWV as it requires only a single radial artery measurement. In the CRIC study, we evaluated how well augmentation index correlated with the carotid-femoral PWV [32] . We had two purposes in mind when undertaking this study. One was to evaluate whether central pressure measures (augmentation index) were a good surrogate for PWV. Secondly, we sought to understand how reproducible, between operators, measures of central pressures and PWV were. We observed a statistically significant but clinically modest correlation (r values of 0.3) between augmentation index and PWV in men and women with CKD. We also observed a mean difference of about 0 m/s, with a SD of 1.1 m/s, between operators for measurement of PWV using Bland-Altman plots [33] . For augmentation index, we found a mean difference of 1% with a SD of 7% using Bland-Altman plots. We suggested that measures of central pressure profile are not a surrogate for an actual measure of central arterial stiffness, though they do reflect arterial stiffness to a degree. On the contrary, PWV, in particular, is a very reproducible measurement as noted by others [34, 35] .
Lesson 10: pulse wave velocity independently predicts 24-h urinary protein excretion in chronic kidney disease in diabetic patients
One difficult concept to disentangle is the relationship between blood pressure and arterial stiffness. This is partly due to the influence that blood pressure has on PWV because blood pressure is a 'loading' characteristic on the vessels, particularly elastic vessels such as the aorta [36] . However, within a cohort, even at the same level of mean arterial pressure, there is a spectrum of PWV values; thus, PWV measures seem to provide information not available from the blood pressure alone. We evaluated this aspect of blood pressure and PWV as factors associated with urinary protein excretion in the CRIC study.
In a sample of 2144 participants from the CRIC study, we observed 24-h urinary excretion of protein to be 790 mg in a population in which approximately 70% were on an angiotensin-converting enzyme (ACE)-inhibitor, or an angiotensin receptor-blocking drug [37] . In these participants, the average blood pressure was 126/71 mmHg, higher in those with diabetes (130/68 mmHg) compared to those without diabetes (120/72 mmHg). The average PWV was 9.4 m/s in these participants, with values averaging 10.6 m/s in those with diabetes compared to 8.6 m/s in those without diabetes.
Each 1 m/s increase in PWV was associated with an increase of 114 mg/day of urine protein loss, and this relationship was significant in the diabetic patients (P < 0.01), but not in those without diabetes (P ¼ 0.11). Each 10 mmHg of SBP increase was associated with 228 mg of urine protein loss and was significant in the diabetic (P < 0.01) but not in the nondiabetic (P ¼ 0.14) groups. In multivariable models adjusted for age, sex, race, eGFR, heart rate, and usage of an ACE-inhibitor or an ARB, both SBP and PWV remained significant and independent predictors of urine protein excretion in the diabetic participants with CKD. Although speculative, greater arterial stiffness may be part of the reason for the more rapid loss of kidney function in diabetic compared with nondiabetic forms of CKD.
CONCLUSION
Arterial stiffness is a strong, independent predictor for a variety of vascular outcomes in a variety of longitudinal population cohorts and in this instance represents an exposure variable. However, arterial stiffness is also an outcome, with blood pressure and age representing the strongest determinants of PWV. Consequently, the ability of PWV to predict outcomes independently of age and blood pressure -two very potent vascular outcome predictors -is further testimony to its clinical utility. The incorporation of measures of PWV into a number of cohorts around the world further supports its value as a cardiovascular risk marker. Attention is turning to ways to de-stiffen the aorta, with at least one randomized clinical trial undertaken in this area -the Statégie de Prévention Cardiovasculaire Basée sur la Rigidité Arterielle Study (SPARTE) in France [38] .
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